These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

836 related items for PubMed ID: 15456992

  • 1. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A, Voskuil DW, Bueno de Mesquita HB, Kaaks R, van Noord PA, Keinan-Boker L, van Gils CH, Peeters PH.
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [Abstract] [Full Text] [Related]

  • 2. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ.
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [Abstract] [Full Text] [Related]

  • 3. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
    Amin S, Riggs BL, Atkinson EJ, Oberg AL, Melton LJ, Khosla S.
    J Bone Miner Res; 2004 Jul; 19(7):1075-83. PubMed ID: 15176989
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA, Borofsky ND, Massardo S, Orentreich N.
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [Abstract] [Full Text] [Related]

  • 5. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
    Hedman CA, Frystyk J, Fridell K, Jönsson A, Flyvbjerg A, Lindström T, Arnqvist HJ.
    Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412
    [Abstract] [Full Text] [Related]

  • 6. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES, Holly JM, Pollak MN, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [Abstract] [Full Text] [Related]

  • 7. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
    Lacey JV, Potischman N, Madigan MP, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lurain JR, Fillmore CM, Sherman ME, Brinton LA.
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):607-12. PubMed ID: 15066926
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE.
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [Abstract] [Full Text] [Related]

  • 9. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S, Riggs BL, Melton LJ, Achenbach SJ, Atkinson EJ, Khosla S.
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [Abstract] [Full Text] [Related]

  • 10. Interactions between insulin, body fat, and insulin-like growth factor axis proteins.
    Ahmed RL, Thomas W, Schmitz KH.
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):593-7. PubMed ID: 17372257
    [Abstract] [Full Text] [Related]

  • 11. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Boillot C, Rinaldi S, Llewellyn M, Chajès V, Clavel-Chapelon F, Téhard B, Chang-Claude J, Linseisen J, Lahmann PH, Pischon T, Trichopoulos D, Trichopoulou A, Zilis D, Palli D, Tumino R, Vineis P, Berrino F, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Pera G, Barricarte A, Chirlaque MD, Quirós JR, Larrañaga N, Martínez-García C, Allen NE, Key TJ, Bingham SA, Khaw KT, Slimani N, Norat T, Riboli E, Kaaks R.
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
    [Abstract] [Full Text] [Related]

  • 12. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
    Barnes BB, Chang-Claude J, Flesch-Janys D, Kinscherf R, Schmidt M, Slanger T, Bonaterra G, Steindorf K.
    Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
    [Abstract] [Full Text] [Related]

  • 13. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Sandri MT, Decensi A.
    Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
    [Abstract] [Full Text] [Related]

  • 14. Effect of nutritional rehabilitation of undernourished rats on serum insulin-like growth factor (IGF)-I and IGF-binding proteins.
    Tovar AR, Halhali A, Torres N.
    Rev Invest Clin; 1999 Nov; 51(2):99-106. PubMed ID: 10410589
    [Abstract] [Full Text] [Related]

  • 15. Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women.
    Jernström H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N, Hudson T, Narod SA, Pollak M.
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):377-84. PubMed ID: 11319179
    [Abstract] [Full Text] [Related]

  • 16. Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women.
    Grønbaek H, Flyvbjerg A, Mellemkjaer L, Tjønneland A, Christensen J, Sørensen HT, Overvad K.
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1759-64. PubMed ID: 15533904
    [Abstract] [Full Text] [Related]

  • 17. Dietary soy and fats in relation to serum insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 levels in premenopausal Japanese women.
    Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K.
    Nutr Cancer; 2003 Nov; 45(2):185-9. PubMed ID: 12881012
    [Abstract] [Full Text] [Related]

  • 18. C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Bezemer ID, Rinaldi S, Dossus L, Gils CH, Peeters PH, Noord PA, Bueno-de-Mesquita HB, Johnsen SP, Overvad K, Olsen A, Tjønneland A, Boeing H, Lahmann PH, Linseisen J, Nagel G, Allen N, Roddam A, Bingham S, Khaw KT, Kesse E, Téhard B, Clavel-Chapelon F, Agudo A, Ardanaz E, Quiros JR, Amiano P, Martínez-Garcia C, Tormo MJ, Pala V, Panico S, Vineis P, Palli D, Tumino R, Trichopoulou A, Baibas N, Zilis D, Hémon B, Norat T, Riboli E, Kaaks R.
    Cancer Causes Control; 2005 Jun; 16(5):561-72. PubMed ID: 15986111
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factors and breast cancer risk in Chinese women.
    Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR, Berkel HJ, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):705-12. PubMed ID: 12163322
    [Abstract] [Full Text] [Related]

  • 20. Effects of pure ethanol and alcopops on glucose, insulin, and the insulin-like growth factor system in healthy subjects.
    Grønbaek H, Flyvbjerg A, Winding P, Frystyk J, Hey H.
    Growth Horm IGF Res; 2005 Aug; 15(4):243-50. PubMed ID: 15925526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.